Efficiency of Melatonin as a Sedative for Auditory Brainstem Response in Children

Anass Chaouki1, Zineb El Krimi1, Amine Mkhatri1

  • 1Faculty of Medicine of Casablanca, Casablanca 20 000, Morocco.

Audiology Research
|November 18, 2020
PubMed

Insights

Melatonin effectively induces sleep for auditory brainstem response (ABR) testing in children, offering a safer alternative to anesthesia. This method proved successful in over 70% of cases, demonstrating its viability in pediatric audiology.

Area of Science:

  • Pediatric Audiology
  • Sleep Medicine
  • Neuroscience

Background:

  • Auditory brainstem response (ABR) testing is crucial in pediatric audiology but often necessitates sedation or general anesthesia.
  • Melatonin has emerged as a safe sleep-inducing agent for pediatric procedures like MRI and EEG.

Purpose of the Study:

  • To evaluate the efficacy of oral melatonin as a substitute for sedation or general anesthesia during ABR testing in children.

Main Methods:

  • 33 children with suspected hearing loss received oral melatonin (5 mg initial dose, with re-administration if needed) for sleep induction.
  • Click-induced ABR tests were conducted on both ears under melatonin-induced sleep.
  • Data on sleep induction, test completion, and patient demographics were collected.

Main Results:

  • ABR testing was successfully completed in 72.7% of children using melatonin-induced sleep.
  • The average time for sleep induction and ABR testing was 45 minutes.
  • Successful completion was significantly associated with receiving a maintenance melatonin dose (p < 0.001) and the degree of hearing loss (p < 0.001).

Conclusions:

  • Melatonin-induced sleep presents a safe and effective alternative to anesthesia for pediatric ABR testing.
  • The administration is simple, well-tolerated by children, and parent-approved.
  • This approach enhances the safety profile of audiological assessments in young children.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
406
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
352
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.1K